| Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages TE Peterson, ND Kirkpatrick, Y Huang, CT Farrar, KA Marijt, J Kloepper, ... Proceedings of the National Academy of Sciences 113 (16), 4470-4475, 2016 | 297 | 2016 |
| Tumor VEGF: VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer S Chatterjee, LC Heukamp, M Siobal, J Schöttle, C Wieczorek, M Peifer, ... The Journal of clinical investigation 123 (4), 1732-1740, 2013 | 228 | 2013 |
| Targeted expression of mutated ALK induces neuroblastoma in transgenic mice LC Heukamp, T Thor, A Schramm, K De Preter, C Kumps, B De Wilde, ... Science translational medicine 4 (141), 141ra91-141ra91, 2012 | 203 | 2012 |
| RETRACTED: Cytohesins Are Cytoplasmic ErbB Receptor Activators A Bill, A Schmitz, B Albertoni, JN Song, LC Heukamp, D Walrafen, ... Cell 143 (2), 201-211, 2010 | 105 | 2010 |
| The bispecific immunoligand ULBP2‐aCEA redirects natural killer cells to tumor cells and reveals potent anti‐tumor activity against colon carcinoma A Rothe, RD Jachimowicz, S Borchmann, M Madlener, J Keßler, ... International Journal of Cancer 134 (12), 2829-2840, 2014 | 62 | 2014 |
| Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy WW Ho, IL Gomes-Santos, S Aoki, M Datta, K Kawaguchi, NP Talele, ... Proceedings of the National Academy of Sciences 118 (45), e2105323118, 2021 | 49 | 2021 |
| Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin M Saif, WJ Kwanten, JA Carr, IX Chen, JM Posada, A Srivastava, J Zhang, ... Nature biomedical engineering 4 (8), 801-813, 2020 | 44 | 2020 |
| Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer S Chatterjee, C Wieczorek, J Schöttle, M Siobal, Y Hinze, T Franz, A Florin, ... Cancer research 74 (10), 2816-2824, 2014 | 34 | 2014 |
| A cerebellar window for intravital imaging of normal and disease states in mice V Askoxylakis, M Badeaux, S Roberge, A Batista, N Kirkpatrick, M Snuderl, ... Nature protocols 12 (11), 2251-2262, 2017 | 25 | 2017 |
| Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models M Datta, S Chatterjee, EM Perez, S Gritsch, S Roberge, M Duquette, ... Proceedings of the National Academy of Sciences 120 (6), e2219199120, 2023 | 24 | 2023 |
| Inhibition of tumor VEGFR2 induces serine 897 EphA2-dependent tumor cell invasion and metastasis in NSCLC C Volz, S Breid, C Selenz, A Zaplatina, K Golfmann, L Meder, F Dietlein, ... Cell reports 31 (4), 2020 | 23 | 2020 |
| Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer J Schöttle, S Chatterjee, C Volz, M Siobal, A Florin, D Rokitta, Y Hinze, ... Oncotarget 6 (36), 38458, 2015 | 21 | 2015 |
| Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes PJ Lei, ER Pereira, P Andersson, Z Amoozgar, JW Van Wijnbergen, ... Journal of Experimental Medicine 220 (9), e20221847, 2023 | 9 | 2023 |
| Molecular analysis of circulating tumor DNA (ctDNA) in patients (pts) with EGFR exon 20 insertion-positive (ex20ins+) advanced NSCLC treated with mobocertinib. S Vincent, Z Su, V Bunn, A Joshi, Z Yu, S Chatterjee, M Guha, P Zhang Journal of Clinical Oncology 40 (16_suppl), 9108-9108, 2022 | 5 | 2022 |
| Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin (vol 4, pg 801, 2020) M Saif, WJ Kwanten, JA Carr, IX Chen, JM Posada, A Srivastava, J Zhang, ... NATURE BIOMEDICAL ENGINEERING 4 (12), 1222-1222, 2020 | 2 | 2020 |
| Abstract LB-346: Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages Z Amoozgar, TE Peterson, ND Kirkpatrick, Y Huang, CT Farrar, KA Marijt, ... Cancer Research 76 (14_Supplement), LB-346-LB-346, 2016 | 2 | 2016 |
| 1241 IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancer R Jain, N Talele, H Kumra, IG Dos Santos, S Roberge, W Ho, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Tmic-07. Dual Inhibition of Ang-2 and Vegf Receptors Normalizes Tumor Vasculature and Prolongs Survival in Glioblastoma By Altering Macrophages T Peterson, N Kirkpatrick, Y Huang, C Farrar, K Marjit, J Kloepper, M Datta, ... Neuro-Oncology 18 (suppl_6), vi201-vi201, 2016 | 1 | 2016 |
| A Bispecific Protein Targeting the NKG2D Receptor on Natural Killer Cells: In Vitro and In Vivo activity of ULBP2-CEA M Madlener, A Rothe, R Jachimowicz, KS Reiners, S Chatterjee, R Ullrich, ... Blood 116 (21), 2095, 2010 | 1 | 2010 |
| Abstract B025: IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancer NP Talele, H Kumra, IL Gomes-Santos, S Roberge, WW Ho, P Andersson, ... Cancer Research 84 (2_Supplement), B025-B025, 2024 | | 2024 |
